#BIOSummit19: Education and Partnerships Raise Awareness
BIOtech Now Theresa Brady When Mark Dant’s son Ryan was first diagnosed with MPS-I, a rare genetic disorder that leads to organ […]
Category: News
Greenwood: Solving the Looming Superbug Crisis Will Require Bold Action From Congress
BIOtech Now Andrew Segerman Writing for Morning Consult, BIO’s Jim Greenwood discusses the challenges of developing novel antibiotics and highlights the urgent […]
Fundraising Companies Find Strategic Partners that Best Fit Their Stage of Development at BIO Investor Forum
BIOtech Now Rufael Seyum Since its inception 17 years ago, the BIO Investor Forum has become the premier event where biotech innovators […]
Investment Crackdown Prompts Chinese Investors to Leave U.S. Biotech Market and Focus on Europe
BIOtech Now Rufael Seyum Confusion among Chinese investors about shifting U.S. regulatory policy is draining billions of dollars from the American biotechnology […]
BIO Mourns Passing of Dr. John Holaday
BIOtech Now Jim Greenwood On behalf of the team at BIO, we send our deepest condolences to the family of Dr. John […]
#TBT: Debunking Some Common Myths on Patent Protections
BIOtech Now Andrew Segerman The Subcommittee on Consumer Protection and Commerce of the Committee on Energy and Commerce is set to examine […]
The Challenges and Risks of Adopting Foreign Price Controls
BIOtech Now Andrew Segerman The Trump Administration is moving forward with a plan to import foreign price controls into Medicare. Under the […]
As Mosquito Fears Rise, EPA Considers Oxitec 2nd Generation Trial
BIOtech Now Karen Batra Most people consider mosquitoes to be a summertime pest – the unwelcome guest at the backyard barbecue. More […]
ICYMI: Biopharmaceutical Companies Aren’t Free-Riding on Government Research
BIOtech Now Andrew Segerman Writing for the Boston Globe, Dr. Michael Rosenblatt, chief medical officer of the venture firm Flagship Pioneering, debunks […]
Discrimination Against Vulnerable Patients Is Nothing New
BIOtech Now Andrew Segerman Transformative therapies are advancing like never before, and a new class of medicines are changing the way we […]
National Immunization Awareness Month Is a Reminder About the Value of Vaccines
BIOtech Now Andrew Segerman Writing for Morning Consult, Dr. Judy Monroe, president and CEO of the CDC Foundation, highlights the importance of […]
The BIO Investor Forum Links Promising Early-Stage Technologies with an Active Investor Network
BIOtech Now Nareg Sagherian As the biopharma industry has gained traction on new drug approvals throughout 2019, the financial dollars have followed […]
New Coalition to Raise Awareness of Antimicrobial Resistance Threat, Call for Urgent Solutions
BIOtech Now Andrew Segerman The Biotechnology Innovation Organization (BIO), leading scientists, public policy experts, and industry leaders today announced the launch of […]
BIO’s Jim Greenwood Talks Pricing, Policy and Science on CSPAN
BIOtech Now Andrew Segerman BIO’s Jim Greenwood joined CSPAN’s Washington Journal for a conversation about drug pricing, the latest proposals being considered […]
Biotech Leaders Warn: Shortsighted Policies Threaten Miracle Breakthroughs
BIOtech Now Andrew Segerman Writing for STAT News, Paul Hastings – CEO of Nkarta Therapeutics and Vice Chair of BIO’s Board – […]
Why Are Patients Facing Higher Costs When They Go to the Pharmacy?
BIOtech Now Andrew Segerman BIO is out with a new whiteboard video that explores why more and more patients are facing higher […]
Technology to Fight Malaria, Zika, and Other Mosquito-Related Diseases Is Being Blocked. Why?
BIOtech Now Josh Falzone Every year, mosquitos infect 500 million people with diseases and mosquito-borne illnesses claim nearly a million lives. Mosquito-related […]
Experts Weigh In on the Dangers of Importing Foreign Price Controls
BIOtech Now Andrew Segerman Experts recently gathered on Capitol Hill to discuss how importing foreign price controls will lead to less innovation […]
New Videos Show How “Fail First” Policies Can Fail Patients
BIOtech Now BIOtechNOW Editor Continued access to a stable treatment can make all the difference for patients with chronic illnesses like arthritis, […]
Rare Disease Drug Development Increases but Challenges Remain
BIOtech Now Andrew Segerman In a recent study published by Tufts University, researchers found that rare disease drug development is now one […]